跳至主要内容
临床试验/NCT05721677
NCT05721677招募中不适用

The Impact of Central-line Exit-site Sealing With 2-octyl Cyanoacrylate Adhesive on CLABSI in Pediatric Cardiac Intensive Care Unit

Rabin Medical Center2 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2023年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
600
试验地点
2
主要终点
CLABSI rate

研究概览

简要总结

Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.

详细描述

Health-care associated infections (HAI) and especially central-line associated blood stream infections (CLABSI) are a well described burden in the intensive care units. There are two main possible pathways leading to central-venous line (CVL) related infection: the first is migration of microbes down the catheter tract (between the CVL and the skin), and the second is via the catheter hub/lumen. Cyanoacrylate adhesive is a commonly used tissue adhesive in children and adults with frequent use in pediatric facial lacerations. Several studies have shown its feasibility and safety in the general pediatric population, including neonates and in children after cardiac surgery.

To our knowledge, no study to date has explored the use of 2-octyl cyanoacrylate at central-line exit site as a mean to decreases pediatric CLABSI.

Our aim is to assess 2-octyl cyanoacrylate association with CLABSI rate in pediatric cardiac intensive care population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
0 Days 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All patients admitted to pediatric cardiac ICU (PCICU) defined as high-risk for CLABSI (any of):
  • young age<1y & Congenital Heart Surgery Mortality Category (STAT\STS-EACTS) score 2-5
  • Risk Adjustment for Congenital Heart Surgery (RACHS) category ≥3
  • preoperative length-of-stay (LOS) >7 days
  • preoperative ventilator support
  • presence of a genetic abnormality
  • extracorporeal membrane oxygenation (ECMO) support

排除标准

  • Patients with on-going bacteremia
  • patients with pre-existing central-line or peripherally inserted central catheter (PICC)
  • parental refusal to participate.

结局指标

主要结局

CLABSI rate

时间窗: up to 1 year

次要结局

  • invasive mechanical ventilation duration(up to 1 year)
  • Postoperative ECMO support(up to 1 year)
  • dressing changes rates(average of 14 days)
  • safety outcome: Number pf participants with contact dermatitis at the catheter exit site, line dislodgement, leak, exit site bleeding, allergic reaction or line tunnel infection(average of 14 days)
  • presence of lung atelectasis(up to 1 year)
  • ICU LOS(up to 1 year)
  • Chylothorax(up to 1 year)
  • Extubation failure(up to 1 year)
  • multidrug resistant bacterial colonization(up to 1 year)
  • Chest drains duration(up to 1 year)
  • need for cardiopulmonary resuscitation (CPR)(up to 1 year)
  • mortality rate(up to 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ERAN SHOSTAK

Principal Investigator

Rabin Medical Center

研究点 (2)

Loading locations...

相似试验